Aidan William Flanagan

Mr. Aidan William Flanagan

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2026 in Sports
Verified
Journal Article
Open access
PDF file
JKJoshua A Kidwell
Joshua A Kidwell
TYTrent Yamamoto
Trent Yamamoto
AFAidan William Flanagan
Aidan William Flanagan
VSVishruth Shatagopam
Vishruth Shatagopam
KHKyle J Hetherton
Kyle J Hetherton
BDBrett Dolezal
Brett Dolezal
High-intensity aquatic sports require athletes to repeatedly produce near-maximal efforts under conditions of constrained ventilation and limited recovery between bouts, placing substantial importance on recovery efficiency. While supplemental oxygen has been proposed as a recovery-targeted strategy to support repeated high-intensity performance, its acute effects in aquatic athletes remain poorly characterized. The purpose of this study was to examine whether brief inhalation of supplemental oxygen during recovery following a maximal swim effort influences subsequent swimming performance and perceived exertion in trained aquatic athletes. Eighteen collegiate-aged male aquatic athletes completed a randomized, placebo-controlled, within-subject crossover protocol. Each condition consisted of a maximal 100-yard (91.44 m) swim followed by a standardized recovery period that included a five second inhalation of either 98% supplemental oxygen or ambient air delivered via an identical portable device, prior to a maximal 50-yard (45.72 m) freestyle sprint. Sprint performance was significantly faster following oxygen-assisted recovery compared with placebo, and perceived exertion was significantly reduced at the post-exercise time point, with no differences observed prior to exercise or mid-protocol. These findings suggest that brief, recovery-targeted hyperoxia may enhance repeated high-intensity swimming performance while attenuating post-exercise perceived exertion in trained aquatic athletes.

19 February 2026 in Journal of Bacteriology
Verified
Journal Article
Open access
WCWilliam Cutts
William Cutts
AFAidan William Flanagan
Aidan William Flanagan
BGBrice K. Gorman
Brice K. Gorman
ASAudrey Sweten
Audrey Sweten
BEBryan J. Estrada
Bryan J. Estrada
Brandon KimBrandon Kim
Brandon Kim
Group B Streptococcus (GBS), a common colonizer of the human genital and gastrointestinal tracts, is a leading cause of neonatal bacterial meningitis, which can lead to severe neurological complications. The hypervirulent serotype III, sequence type 17 (ST-17) strain COH1 is strongly associated with late-onset disease due to its unique set of virulence factors. However, genetic manipulation of ST-17 strains remains challenging, limiting the ability to study key pathogenic genes. In this study, we developed a CRISPR interference (CRISPRi) system utilizing an endogenous catalytically inactivated Cas9 (dCas9) in the COH1 strain, enabling targeted and tunable gene expression knockdown. We confirmed the efficacy of this system through hemolysis assays, qPCR transcriptional analysis, and in vitro infection models using human brain endothelial cells. The CRISPRi system successfully produced phenotypic knockdowns of key virulence genes, including PI-2b, srr2 , and iagA , reducing adhesion, invasion, and inflammatory responses at the blood-brain barrier (BBB). This platform enables rapid gene knockdowns for functional genomics in ST-17 GBS, enabling high-throughput screening and pathogenesis research. IMPORTANCE: Group B Streptococcus (GBS) remains the world's leading cause of neonatal meningitis. GBS-host interactions at the blood-brain barrier (BBB) are dependent on bacterial factors, including surface factors and two-component systems. Multi-locus sequence type 17 (ST-17) GBS strains are highly associated with neonatal meningitis, and these strains harbor many virulence factors for infection at the BBB. Historically, these factors have been studied using traditional knockout mutagenesis, which has been challenging in the most common ST-17 lab strain, COH1. This study utilizes CRISPR interference (CRISPRi) to generate rapid expression knockdown. This study validates a CRISPRi-enabled COH1 dCas9 strain as a versatile tool for probing GBS pathogenesis at the BBB.

27 August 2025 in bioRxiv
Verified
Preprint
Open access
WCWilliam Cutts
William Cutts
AFAidan William Flanagan
Aidan William Flanagan
BGBrice Gorman
Brice Gorman
ASAudrey Sweten
Audrey Sweten
BEBryan Estrada
Bryan Estrada
Brandon KimBrandon Kim
Brandon Kim
Group B Streptococcus (GBS), a common colonizer of the human genital and gastrointestinal tracts, is a leading cause of neonatal bacterial meningitis, which can lead to severe neurological complications. The hypervirulent serotype III, sequence type 17 (ST-17) strain COH1 is strongly associated with late-onset disease due to its unique set of virulence factors. However, genetic manipulation of ST-17 strains is notoriously challenging, limiting the ability to study key pathogenic genes. In this study, we developed a CRISPR interference (CRISPRi) system utilizing an endogenous catalytically inactivated Cas9 (dCas9) in the COH1 strain, enabling targeted and tunable gene expression knockdown. We confirmed the efficacy of this system through hemolysis assays, qPCR transcriptional analysis, and in vitro infection models using human brain endothelial cells. The CRISPRi system successfully produced phenotypic knockdowns of essential virulence genes, including pilA, srr2 , and iagA , reducing adhesion, invasion, and inflammatory responses at the blood-brain barrier. This platform enables rapid gene knockdowns for functional genomics in ST-17 GBS, enabling high-throughput screening and pathogenesis research. Importance: Group B Streptococcus (GBS) remains the world’s leading cause of neonatal meningitis. GBS-host interactions at the blood-brain barrier (BBB) are dependent on bacterial factors, including surface factors and two-component systems. Multi-locus sequence type 17 (ST-17) GBS strains are highly associated with neonatal meningitis, and these strains harbor many virulence factors for infection at the BBB. Historically, these factors have been studied using traditional knockout mutagenesis, which has proven challenging in the most common ST-17 lab strain, COH1. This study utilizes CRISPR interference (CRISPRi) to generate rapid expression knockdown. This study validates a CRISPRi-enabled COH1 dCas9 strain as a versatile tool for probing GBS pathogenesis at the BBB.

9 July 2026 in Microbiology Resource Announcements
Verified
Journal Article
Open access
WCWilliam Cutts
William Cutts
ASAustin D. Sandobal
Austin D. Sandobal
AFAidan William Flanagan
Aidan William Flanagan
BGBrice K. Gorman
Brice K. Gorman
Brandon KimBrandon Kim
Brandon Kim
We present a comprehensive, in silico -designed CRISPR interference (CRISPRi) sgRNA database targeting the hypervirulent Streptococcus agalactiae strain COH1. This resource provides broad, redundant, and cross-strain functional coverage, enabling scalable CRISPRi-based interrogation of conserved and strain-specific determinants of GBS biology, colonization, and pathogenesis.